At a glance
ClinicalIndex Comparison RecordN/ACompleted· 381 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Efficacy and Tolerability of Venoactive Drugs in Combination Therapy and Their Effect on the Overall Treatment Outcomes in Patients With Chronic Venous Diseases of CEAP Class C4a and C4b in Real Clinical Practice.
In Brief
An observational study for Chronic Venous Diseases. Completed, enrolled 381 participants across 1 site.
Detailed Summary
The study is aimed at evaluating the efficacy and tolerability of systemic pharmacotherapy as a part of combination treatment, and its influence on the overall treatment outcomes in patients with skin changes (CEAP class C4a and C4b).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Venous Diseases
CountriesRussia
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartDec 2019
Primary CompletionOct 2020
Study CompletionDec 2020
TodayJul 2026
First PostedOct 24, 2019
Enrollment StartDec 25, 2019
Primary CompletionOct 1, 2020
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.7 years ago